19 Severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in 2002 as a highly 20 transmissible pathogenic human betacoronavirus. The viral spike glycoprotein (S) utilizes 21 angiotensin-converting enzyme 2 (ACE2) as a host protein receptor and mediates fusion of the 22
viral and host membranes, making S essential to viral entry into host cells and host species 23 tropism. As SARS-CoV enters host cells, the viral S undergoes two proteolytic cleavages at 24 S1/S2 and S2ʹ′ sites necessary for efficient membrane fusion. Here, we present a cryo-EM 25 analysis of the trimeric SARS-CoV S interactions with ACE2 and of the trypsin-cleaved S. 26 Surprisingly, neither binding to ACE2 nor cleavage by trypsin at the S1/S2 cleavage site impart 27 large conformational changes within S or expose the secondary cleavage site, S2´. These 28 observations suggest that S2´ cleavage does not occur in the S prefusion conformation and that 29 additional triggers may be required. 30 3 Severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in humans in 2002 31 and rapidly spread globally causing 8,096 cases and 774 associated deaths in 26 countries 32 through July 2003 1 . SARS-CoV reappeared in a second smaller outbreak in 2004, but has since 33 disappeared from human circulation. However, closely related coronaviruses, such as WIV1, 34 currently circulate in bat reservoirs and are capable of utilizing human receptors to enter cells 2 . 35 The more recent emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) 1 and 36 the likelihood of future zoonotic transmission of novel coronaviruses to humans from animal 37 reservoirs make understanding the coronavirus infection cycle of great importance to human 38 health. 39 Coronaviruses are enveloped viruses possessing large, trimeric spike glycoproteins (S) 40 required for the recognition of host receptors for many coronaviruses as well as the fusion of 41 viral and host cell membranes for viral entry into cells 3 . During viral egress from infected host 42 cells, some coronavirus S proteins are cleaved into S1 and S2 subunits. The S1 subunit is 43 responsible for host-receptor binding while the S2 subunit contains the membrane-fusion 44 machinery. During viral entry, the S1 subunit binds host receptors in an interaction thought to 45 expose a secondary cleavage site within S2 (S2´) adjacent to the fusion peptide for cleavage by 46 host proteases 4-7 . This S2´ proteolysis has been hypothesized to facilitate insertion of the fusion 47 peptide into host membranes after the first heptad repeat region (HR1) of the S2 subunit 48 rearranges into an extended α-helix 8-10 . Subsequent conformational changes in the second heptad 49 repeat region (HR2) of S2 form a six-helix bundle with HR1, fusing the viral and host 50 membranes and allowing for release of the viral genome into host cells. Coronavirus S is also the 51 target of neutralizing antibodies 11 , making an understanding of S structure and conformational 52 transitions pertinent for investigating S antigenic surfaces and designing vaccines. The SARS-CoV S1 subunit is composed of two distinct domains: an N-terminal domain 54 (S1 NTD) and a receptor-binding domain (S1 RBD) also referred to as the S1 CTD or domain B. 55 Each of these domains have been implicated in binding to host receptors, depending on the 56 coronavirus in question. However, most coronaviruses are not known to utilize both the S1 NTD 57 and S1 RBD for viral entry 12 . SARS-CoV makes use of its S1 RBD to bind to the human 58 angiotensin-converting enzyme 2 (ACE2) as its host receptor 13,14 . 59 Recent examination using cryo-electron microscopy (cryo-EM) has illuminated the 60 prefusion structures of coronavirus spikes [15] [16] [17] [18] [19] [20] [21] [22] . Initial examination of HCoV-HKU1 S showed 61 that the receptor-binding site on the S1 RBD was occluded when the RBD was in a 'down' 62 conformation and it was hypothesized that conformational changes were required to access this 63 site 16 . Subsequent studies of the highly pathogenic human coronavirus S proteins of SARS- 64 CoV 15, 22 showed that these viral S1 RBD do indeed sample an 'up' 65 conformation where the receptor-binding site is accessible. These structural studies also located 66 the positions of the S1/S2 and S2´ cleavage sites on the prefusion spike. The S1/S2 site lies 67 within a surface exposed loop in the second subdomain of S1 16 . However, the S2´ site lies closer 68 to base of the spike and though this region is located on the surface of the spike, cleavage at this 69 site is prevented by surrounding protein elements 17 . 70 To examine the hypothesized conformational transitions induced by proteolysis and 71 receptor binding, we used single-particle cryo-EM to determine structures of S in uncleaved, 72 S1/S2 cleaved and ACE2-bound states. Three-dimensional classification of the S1 RBD 73 positions and corresponding atomic protein models revealed that neither ACE2-binding nor 74 trypsin cleavage at the S1/S2 boundary induced substantial conformational changes in the Supplementary Fig. 1 ). The S1 NTD and some of the S1 RBD, while clearly present, appear 89 poorly resolved in the cryo-EM maps, precluding a de novo build of these regions. For this 90 reason, available SARS-CoV S crystal structures 22,23 of corresponding domains were placed into 91 these densities. Overall, the SARS-CoV S 2P structure resembles that of other coronaviruses, 92 particularly those of the betacoronavirus genus 16, 17, 19, 22 and the previously published SARS-CoV 93 wild-type prefusion ectodomains 15, 22 . The S1 domains surround the helical S2 subunits and 94 interdigitate at the membrane-distal apex of the trimeric spike. The structure of the S2 subunit 95 appears to be highly conserved across coronavirus genera 18, 20, 21 . The SARS-CoV prefusion wild- CoV may use a distinct mechanism of FP2 membrane insertion. 110 As observed in the previous SARS-CoV and MERS-CoV S structures 15,22 , the trimeric S 111 adopts two distinct conformations related to each of the S1 RBD. The 'down' conformation caps 112 the S2 helices and makes extensive contacts with the S1 NTD. The 'up' conformation of the S1 113 RBD exposes the S1 RBD receptor-binding site. It has been previously reported that for wild-114 type SARS-CoV S, 56% of the particles contained three 'down' RBD conformations while 44% 115 contained a single 'up' S1 RBD conformation 22 . To examine the conformation of the S1 RBD 116 among our SARS-CoV S 2P ectodomains, we used a local masking and 3-D sorting strategy 17 to 117 more accurately classify the conformations as being either 'down' or 'up' at each of the three S1 118 RBD positions within the trimer. This analysis revealed that the majority of the S 2P proteins 119 were in the single-'up' conformation (58%) with lesser amounts of double-and triple-'up' 120 conformations (39% and 3% respectively) and with no all-'down' conformation observed. The 7 increased propensity to adopt the 'up' S1 RBD conformation may indicate a difference in the 122 coronavirus S containing the 2P mutations, however other differences in sample preparation 123 cannot be ruled out. 124 125 ACE2 and S1 C-terminal domains 126 To examine the structure of SARS-CoV S bound to its receptor, ACE2, we combined 127 SARS-CoV S 2P ectodomain with an excess of soluble human ACE2 with subsequent 128 purification by size-exclusion chromatography and immediate cryo-EM specimen preparation. 129 Initial sorting of particle heterogeneity indicated spikes could be split into ACE2-bound (45%) 130 and unbound (55%) classes. Using a similar masking and 3-D sorting strategy as above we sorted 131 the unbound S class further into classes with S1 conformations of one or two 'up' S1 RBDs ( Fig   132   3 and Supplementary Tables 2-4 and Supplementary Fig. 2-4 ). We did not observe an all-'down' 133 class nor a three 'up' S1 RBD class indicating a low prevalence of these conformations among 134 the unbound spikes. Expanding our 3D sorting strategy, we classified our ACE2-bound particles 135 at each S1 RBD position and identified single, double and triple ACE2-bound S. We were 136 further able to identify S1 RBD conformations at the non-ACE2 occupied RBD positions to 137 represent each population of S1 RBD conformations among ACE2-bound S. 138 As hypothesized by previous structural work [15] [16] [17] 22 , the S1 RBD recognizes ACE2 with 139 an 'up' S1 RBD conformation. The proportion of total 'up' S1 RBD conformations within the 140 ACE2-bound and -unbound classes is nearly identical within this dataset (58% 'up' S1 RBD), 141 similar to the proportion of total 'up' S1 RBD in the SARS S 2P ectodomain dataset (48%). This 142 strongly suggests that binding of a single ACE2 receptor does not induce adjacent S1 RBDs to 143 transition from a 'down' to 'up' conformation. Hence, ACE2 is more likely to bind to an already 144 8 'up' S1 RBD rather than inducing the conformational changes that are required for the S1 RBD 145 to become accessible to ACE2. 146 It is noteworthy that despite prolonged co-incubation and an excess of ACE2, we had 147 difficulties in saturating the S1 RBD with ACE2 in the context of trimeric S ectodomain. This 148 poor saturation is illustrated by the small proportion of triple-bound ACE2 and the majority of 149 spikes that are unbound by receptor. In contrast, isolated recombinant S1 RBD easily binds 150 ACE2 and is capable saturating ACE2 on target cells to block S-mediated entry 14 . Our observed 151 sub-stoichiometric ACE2 binding to trimeric spikes is consistent with the difficulty in using 152 soluble ACE2 receptor to neutralize SARS-CoV S pseudotyped onto VSV 25 . The reduced 153 binding of ACE2 to trimeric spikes is likely due to the incomplete exposure and conformational 154 flexibility of the S1 RBD. Incomplete neutralization with soluble receptor was not encountered 155 for MHV which binds CEACAM1a via its S1 NTD, which does not undergo conformational 156 changes 19,26 . 157 Similar to recently published MERS-CoV S structures 17 , the ACE2-bound RBD adopts a 158 much more extended and rotated conformation compared to S1 RBD modeled in previous 159 SARS-CoV S structures 22 . This difference is likely due to poor density in the hinge regions 160 between the S1 RBD and subdomain 1 (SD-1) in these previous reconstructions 15,22 rather than 161 the presentation of a unique receptor-bound conformation. Indeed, the bound ACE2 receptor and 162 S1 RBD for all reconstructions here show poorer density quality than the less mobile regions of 163 the SARS-CoV S (Fig 4) . To improve the density for ACE2-bound S1 RBD, we used focused 164 refinement on this region to overcome the flexibility of these domains relative to the rest of S. 165 This yielded a 7.9 Å resolution reconstruction with improved local density quality (Fig 4b and c) . 166 We successfully placed the crystal structure of the SARS-CoV S1 RBD bound to ACE2 167 9 (2AJF.pdb 23 ) into this density as a rigid body indicating that the previously determined crystal 168 structure accurately recapitulates the conformation between the ACE2-bound S1 RBD in the 169 trimeric spike. 170 The ACE2-bound, S1 RBD extends upwards and rotates away from contacts with nearby 171 amino acids. Hence, any conformational changes induced by receptor binding to the S1 RBD are 172 more likely to be caused by the absence of the S1 RBD contacts in the 'up' conformation, rather 173 than the formation of additional contacts (Supplemental Figure 5) . This model provides a flexible 174 mechanism for how different coronavirus spikes can bind to different protein receptors with their 175 S1 RBD and facilitate fusion with host cells. Moreover, movements of the S1 RBD to the 'up' upper portion of this helix has transitioned to a 3 10 -helix ( Fig. 4d and e ). This subtle transition 191 may indicate that conformational changes towards fusion are initiated in the central helix. N-192 terminal to the central helix are the 2P mutations that stabilize the spike in its prefusion 193 conformation. These stabilizing mutations may block the propagation of conformational changes 194 beyond the subtle change to a short 3 10 -helix, providing a possible mechanism for their prefusion 195 stabilizing effect. all four samples are cleaved to S1 and S2 products at equivalent rates at similar sites 213 11 ( Supplementary Fig. 6 ). Nearing the end of the time course additional lower molecular weight 214 bands are observed which we interpret to be degradation of the S1 subunit. Regardless of which 215 construct was used or whether ACE2 was bound to the S ectodomains, there is no prominent 216 band that corresponds to a S2ʹ′ cleavage product (approximately 52 kDa). 217 To analyze the cleavage products in detail, we performed cryo-EM analysis on the 218 trypsin-cleaved SARS-CoV S 2P ectodomain. Using all-particles and C3 symmetry yielded a 219 reconstruction at 3.3 Å resolution (Fig. 5, Supplementary Tables 1 and 4 and Supplementary Fig.   220 7). The short loop containing the S1/S2 cleavage site is disordered in the uncleaved spike 221 reconstruction and remains disordered in the trypsin cleaved reconstruction. Moreover, 222 examination of the structure models indicates no significant differences between the trypsin-223 cleaved and uncleaved SARS-CoV S (Fig. 5b) . Fine sorting of S1 RBD positions of the trypsin-224 cleaved S reveals a very similar distribution of 'up' S1 RBD conformations available for receptor 225 binding as in the uncleaved samples, although we additionally observe a small proportion of S1 226 RBD in the all-'down' conformation ( Fig. 5c ). These results indicate that trypsin-cleavage at 227 S1/S2 does not impart large conformational changes on the SARS-CoV S and justifies the 228 removal of S1/S2 cleavage sites for the production of more homogeneous material as vaccine 229 immunogens. This suggests that although cleavage at S1/S2 may remove an obstacle for 230 conformational changes leading to fusion, S1/S2 cleavage alone does not produce significant 231 conformational changes. 232 In agreement with the in vitro limited proteolysis experiments, the S2ʹ′ site remains 233 uncleaved in the trypsin-cleaved spike ectodomain structures. The arginine at the proposed S2ʹ′ 234 cleavage site in all coronavirus spike structures published to date and presented here is blocked 235 from cleavage by a loop protruding from just N-terminal to the fusion peptide and by an N-236 terminal helix of S2 HR1 (Fig 6) . Exposure of this site for cleavage may require remodeling of 237 this penultimate loop or HR1 beyond the conformation observed in the prefusion state. We 238 hypothesize that additional triggers beyond cleavage at the S1/S2 site or protein-receptor binding 239 are needed to transition the spike from its prefusion state to a yet to be observed intermediate. Here, we present the first structures of a trimeric coronavirus spike ectodomain bound to 253 a protein receptor as well as the first structures of prefusion S1/S2 cleaved coronavirus spikes. 254 Our structures of the SARS-CoV S 2P ectodomain bound to a soluble form of human ACE2 255 receptor show that any conformational changes induced in S by receptor binding are more likely 256 to be due to the disruption of protein-protein interactions rather than the formation of additional 257 contacts between the S1 RBD and other regions of S ( Supplemental Fig. 5 ). The only 258 conformational change that we observe in the ACE2-bound structures is the transition to a short 259 13 3 10 -helix at the top of the S2 central α-helix when uncapped by receptor-bound S1 RBD 260 suggesting that more extensive conformational changes may be initiated here. The 2P prefusion 261 stabilizing mutations adjacent to this region may block more extensive transitions from 262 occurring. However, both wild-type and 2P SARS-CoV S ectodomains bound to ACE2 were 263 cleaved equally by trypsin, indicating that at least at the level of protease susceptibility, these 264 two receptor-bound complexes are equivalent. 265 Our examinations of both receptor-bound and trypsin-cleaved prefusion SARS-CoV S 266 proteins indicate that neither receptor binding nor trypsin cleavage induces large conformational 267 changes in S and do not expose the S2′ cleavage site for proteolysis. These data suggest that 268 SARS coronavirus spikes may require an additional factor to undergo such conformational 269 changes and that the S2′ proteolysis does not occur in the S prefusion state (Fig. 7) . This Proline-substituted variant harboring K968P and V969P mutations was generated based on this 282 14 construct. The resulting plasmids, designated SARS S WT and SARS S 2P respectively, were 283 transfected into 1 L FreeStyle 293-F cells (Life Technologies). 293-F cells were used without 284 validation and were not tested for mycoplasma. Three hours after transfection, kifunensine was 285 added to a final concentration of 5 µM. Cultures were harvested after 6 d, and protein was 286 purified from the supernatant using Strep-Tactin resin (IBA). HRV3C protease (1% wt/wt) was 287 added to the protein and the reaction was incubated overnight at 4 °C. The digested protein was 288 further purified using a Superose 6 16/70 column (GE Healthcare Life Sciences).
289
A gene encoding human ACE2 residues 1-615 with an HRV3C cleavage site, an 8xHis-290 tag and a Twin-Strep-tag was synthesized and subcloned into the eukaryotic-expression vector 291 pαH. This protein was expressed as described above for S proteins. The HRV3C digested ACE2 292 protein was further purified using a Superdex 200 column (GE Healthcare Life Sciences). 293 To make complexes of SARS S 2P with soluble ACE2, the two proteins were combined 294 in a 1:1.1 molar ratio prior to overnight incubation and size-exclusion chromatography on a 295 Superose 6 Increase 10/300 (GE Healthcare Life Sciences).
296
Electron microscopy data collection 297 3 µL of 0.47 mg/mL of protein or protein complexes were mixed with 1 µL of 0.04 % 298 (w/v) amphipol A8-35 (Anatrace) just prior to grid preparation. 3 µL of the protein mixture, final 299 concentration 0.35 mg/mL, was spotted on to plasma cleaned C-flat grids with a 2 µm/2 µm 300 spacing. Grids were blotted for 3 seconds before plunge freezing in liquid ethane on a Vitrobot. 301 Grids were loaded onto a Titan Krios and data was collected using Leginon 32 at a total dose of 65 302 e -/Å 2 . Frames were aligned with MotionCor2 (UCSF) 33 implemented in the Appion workflow 34 . 303 Particles were selected using DoG picker 35 . Images were assessed and particle picks were 304 masked using EM Hole Punch 36 . The CTF for each image was estimated using Gctf 37 . 305 
